Dopamine receptor subtype 2 and somatostatin receptor subtype 5 expression influences somatostatin analogs effects on human somatotroph pituitary adenomas in vitro.

Source:http://linkedlifedata.com/resource/pubmed/id/16216913

Download in:

View as

General Info

PMID
16216913